AIRLINK 77.84 Decreased By ▼ -2.55 (-3.17%)
BOP 4.87 Decreased By ▼ -0.05 (-1.02%)
CNERGY 4.28 Decreased By ▼ -0.07 (-1.61%)
DFML 45.00 Decreased By ▼ -0.51 (-1.12%)
DGKC 85.97 Decreased By ▼ -2.83 (-3.19%)
FCCL 22.45 Decreased By ▼ -1.11 (-4.71%)
FFBL 32.00 Decreased By ▼ -1.00 (-3.03%)
FFL 9.50 Decreased By ▼ -0.07 (-0.73%)
GGL 10.09 Decreased By ▼ -0.18 (-1.75%)
HASCOL 6.55 Decreased By ▼ -0.16 (-2.38%)
HBL 112.00 Decreased By ▼ -1.00 (-0.88%)
HUBC 141.20 Decreased By ▼ -1.36 (-0.95%)
HUMNL 10.97 Decreased By ▼ -0.93 (-7.82%)
KEL 4.85 Decreased By ▼ -0.19 (-3.77%)
KOSM 4.35 Decreased By ▼ -0.15 (-3.33%)
MLCF 38.25 Decreased By ▼ -0.68 (-1.75%)
OGDC 128.89 Decreased By ▼ -3.11 (-2.36%)
PAEL 25.51 Decreased By ▼ -0.24 (-0.93%)
PIBTL 6.36 Decreased By ▼ -0.21 (-3.2%)
PPL 117.50 Decreased By ▼ -2.05 (-1.71%)
PRL 25.80 Decreased By ▼ -0.30 (-1.15%)
PTC 13.74 Decreased By ▼ -0.32 (-2.28%)
SEARL 57.09 Decreased By ▼ -0.42 (-0.73%)
SNGP 64.99 Decreased By ▼ -1.11 (-1.68%)
SSGC 10.00 Decreased By ▼ -0.19 (-1.86%)
TELE 8.12 Decreased By ▼ -0.20 (-2.4%)
TPLP 10.35 Decreased By ▼ -0.21 (-1.99%)
TRG 65.24 Decreased By ▼ -2.91 (-4.27%)
UNITY 26.85 Decreased By ▼ -0.28 (-1.03%)
WTL 1.34 Decreased By ▼ -0.01 (-0.74%)
BR100 7,835 Decreased By -96.8 (-1.22%)
BR30 25,245 Decreased By -504.5 (-1.96%)
KSE100 74,667 Decreased By -908.6 (-1.2%)
KSE30 23,919 Decreased By -292.9 (-1.21%)

KARACHI: Roche Diagnostics Pakistan has introduced an innovative product CoaguChek INRange for the patients on warfarin therapy, enabling them to frequently check their International normalized ratio (INR) values conveniently and easily share the results with their consultant via their phone or any other computing device for quick and efficient therapy management.

CoaguChek INRange in partnership with Dawaai.pk will enable users to easily get their result in just one minute by a single drop of blood. This solution will save patients, especially the bed ridden and elderly ones from the hassle of going to the laboratory for testing over and over again followed by visits to their consultants.

According to research conducted by Australian Point of Care Practitioners and Integrated Cardiovascular Clinical Network, Country Health South Australia, published in US National Library of Medicine, National Institutes Health USA, regular monitoring of the anticoagulant effect is required and evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients. With this solution, patients can easily perform the test at their convenience anywhere. This solution is available nationwide at dawaai.pk where professional pharmacists and consultants are available to guide and educate the patients.

Copyright Business Recorder, 2021

Comments

Comments are closed.